Loading...
XKRX
044820
Market cap90mUSD
Dec 05, Last price  
13,910.00KRW
1D
0.58%
1Q
-24.36%
Jan 2017
-62.81%
IPO
239.29%
Name

Cosmax BTI Inc

Chart & Performance

D1W1MN
XKRX:044820 chart
P/E
8.08
P/S
0.22
EPS
1,722.17
Div Yield, %
—
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
5.00%
Revenues
597.63b
-4.93%
82,538,385,000114,546,398,000154,217,118,000192,451,188,000244,001,150,250312,552,367,360379,008,424,320135,906,970,700199,869,310,100266,924,996,310298,287,327,230438,275,251,190468,352,868,370525,904,306,470575,998,201,640617,403,775,020628,597,019,220597,630,263,000
Net income
16.46b
+81.60%
-1,681,352,0001,556,924,0009,797,404,0008,851,237,00011,508,716,00020,485,675,00021,928,037,00013,554,745,0508,002,588,00015,356,047,4303,844,182,7109,503,200,350-13,904,654,340-17,174,579,6104,343,190,420-20,235,925,0709,061,400,05016,455,097,000
CFO
23.84b
-19.97%
-4,352,108,00011,850,649,0004,367,305,0003,510,352,00016,792,897,99011,545,222,65013,461,263,2406,052,425,05023,905,379,41012,759,533,88010,890,467,690-1,358,392,340-5,674,823,56041,467,271,480-22,348,15029,958,706,17029,784,900,24323,836,080,000
Dividend
Dec 27, 2023350 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Cosmax BTI, Inc. engages in the development, production, and supply of beauty products, health functional foods, pharmaceuticals, and special containers and equipment for customers in South Korea. The company offers sun and foundation creams; makeup creams and bases; hair and cleansing products; mascara and nail products; various color formulations and skin tones; lip sticks and shadows; lip essence and liquid products; body and mask sheets; powder pact products and makeup pencils; and fragrance products. It exports its products to approximately 30 countries. The company was founded in 1992 and is headquartered in Seongnam, South Korea.
URL
http://www.cosmaxbti.com/
IPO date
Nov 13, 2006
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT